MAPT and Alzheimer disease: Studies by Iliff et al. first highlighted the role of the glymphatic system in neurodegenerative diseases, showing that waste products associated with Alzheimer’s disease (AD), such as amyloid beta protein and tau oligomers, are transported and cleared from the brain through the glymphatic system [4].